Coherus

Coherus Oncology is a commercial-stage firm focused on LOQTORZI, a PD1 inhibitor, and clinical candidates for liver, lung, and head and neck cancers.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2014
Stage of Initial Investment
Series C
Initial Investment Year
2014
Coherus Portco Hover Image